|
GW Pharmaceuticals PLC - Company Profile Snapshot
| Company Profile: |
GW Pharmaceuticals PLC |
| Ticker: |
GWP |
| Exchanges: |
LON |
| 2008 Sales: |
11,774,000 |
| Major Industry: |
Miscellaneous |
| Sub Industry: |
Medical Services |
| Country: |
UNITED KINGDOM |
| Employees: |
113 |
Business Description
GW Pharmaceuticals PLC. The Group's principal activity is developing a range of new medicines based on cannabis and other controlled drugs. The Group's lead programme is the development of a portfolio of cannabinoid medicines, including Sativex, to meet patient needs in a wide range of therapeutic indications. The principal initial target areas are Multiple Sclerois (MS) spasticity, neuropathic pain, neuropathic pain in MS and cancer pain. The Group's research also includes the use of other controlled drugs in conjunction with its proprietary secure drug dispensing technology. The Group operates predominantly in the United Kingdom.
|
Not the Report you are looking for?
Click here for more browsing options.
|
The following information is available to subscribers or can be accessed by purchasing the Company Profile Report:
|
- Address (mailing), Phone Number, Web Address
- Earnings/Dividends
- Employees
- Exchanges Listed
- Financial Ratio Analysis |
- Recent Stock Performance
- Sales (recent year)
- Senior Officers
- Shareholder Information
- Stock Analysis Summary |
Layout and Content of a Typical Report
|
|
|
|
|
